Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/119732
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer |
Author: | Ponnusamy, S. Coss, C. Thiyagarajan, T. Watts, K. Hwang, D.-J. He, Y. Selth, L. McEwan, I. Duke, C. Pagadala, J. Singh, G. Wake, R. Ledbetter, C. Tilley, W. Moldoveanu, T. Dalton, J. Miller, D. Narayanan, R. |
Citation: | Cancer Research, 2017; 77(22):6282-6298 |
Publisher: | American Association for Cancer Research |
Issue Date: | 2017 |
ISSN: | 0008-5472 1538-7445 |
Statement of Responsibility: | Suriyan Ponnusamy, Christopher C. Coss, Thirumagal Thiyagarajan, Kate Watts, Dong-Jin Hwang, Yali He, Luke A. Selth, Iain J. McEwan, Charles B. Duke, Jayaprakash Pagadala, Geetika Singh, Robert W. Wake, Christopher Ledbetter, Wayne D. Tilley, Tudor Moldoveanu, James T. Dalton, Duane D. Miller and Ramesh Narayanan |
Abstract: | Abstract not available |
Keywords: | Cell Line, Tumor Animals Mice, Inbred NOD Mice, Knockout Humans Mice, SCID Anilides Indoles Receptors, Androgen Xenograft Model Antitumor Assays Gene Expression Profiling Cell Proliferation Gene Expression Regulation, Neoplastic Alternative Splicing Molecular Structure Male Androgen Receptor Antagonists Prostatic Neoplasms, Castration-Resistant |
Rights: | © 2017 American Association for Cancer Research. |
DOI: | 10.1158/0008-5472.can-17-0976 |
Published version: | http://dx.doi.org/10.1158/0008-5472.can-17-0976 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.